MedTrace Logo

Acute Nerve Stimulation For Enhancing Human and Cognitive Performance

NCT05675956 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2024-03-28

No results posted yet for this study

Summary

The goal of this clinical trial is to test a wearable device's effect on performance in tactical populations with a history of concussion. The main question it aims to answer is the effectiveness of the device on modulate physiological and cognitive function.

The physiological function will be derived from metrics of heart rate variability and blood-based biomarkers, whilst human performance will be evaluated using tasks that assess cognitive domains of executive function, reaction time, and memory.

Conditions

  • Concussion, Mild
  • Autonomic Nervous System
  • Cognitive

Interventions

DEVICE

Experimental group with 100% intensity setting on Apollo Neuro device

The group will have the device set to 100% intensity at one of their two experimental visits.

DEVICE

Active Comparator group with 10% intensity setting on the Apollo Neuro device

The group will have the device set to 10% intensity at one of their two experimental visits.

Sponsors & Collaborators

  • University of South Carolina

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-15
Primary Completion
2024-03-27
Completion
2024-03-27

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05675956 on ClinicalTrials.gov